J. D. Stanaway, A. D. Flaxman, M. Naghavi, C. Fitzmaurice, T. Vos et al., The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013, Lancet, vol.388, pp.1081-1089, 2016.

S. Hallager, P. Brehm-christensen, S. Ladelund, R. Clausen, M. Lund-laursen et al., Mortality rates in patients with chronic hepatitis C and cirrhosis compared with the general population: a Danish cohort study, J Infect Dis, vol.215, pp.192-201, 2017.

L. Degenhardt, A. Peacock, S. Colledge, J. Leung, J. Grebely et al., Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review, Lancet Glob Health, vol.5, pp.1192-1207, 2017.

, Hepatitis C among drug users in Europe: epidemiology, treatment and prevention, 2016.

J. Grebely, S. Larney, A. Peacock, S. Colledge, J. Leung et al., Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs, Addiction, vol.114, pp.150-66, 2019.

J. Grebely, G. J. Dore, S. Morin, J. K. Rockstroh, and M. Klein, Elimination of HCV as a public health concern among people who inject drugs by 2030-what will it take to get there?, J Int AIDS Soc, vol.20, p.22146, 2017.

M. Jauffret-roustide, L. Strat, Y. Couturier, E. Thierry, D. Rondy et al., A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design, BMC Infect Dis, vol.9, p.113, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00663624

J. V. Lazarus, I. Sperle, M. Maticic, and L. Wiessing, A systematic review of hepatitis C virus treatment uptake among people who inject drugs in the European region, BMC Infect Dis, vol.14, p.16, 2014.

J. F. Dillon, J. V. Lazarus, and H. A. Razavi, Urgent action to fight hepatitis C in people who inject drugs in Europe, Hepatol Med Policy, vol.1, issue.2, 2016.

M. Schaefer, R. Sarkar, and C. Diez-quevedo, Management of Mental Health Problems Prior to and during treatment of hepatitis C virus infection in patients with drug addiction, Clin Infect Dis, vol.57, pp.111-117, 2013.

E. M. Goldner, A. Lusted, M. Roerecke, J. Rehm, and B. Fischer, Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among nonmedical prescription opioid users in substance use treatment: systematic review and meta-analyses, Addict Behav, vol.39, pp.520-551, 2014.

C. Rossi, Z. A. Butt, S. Wong, J. A. Buxton, N. Islam et al., Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large populationbased cohort, J Hepatol, vol.69, pp.1007-1021, 2018.

J. Grebely, B. Hajarizadeh, and G. J. Dore, Direct-acting antiviral agents for HCV infection affecting people who inject drugs, Nat Rev Gastroenterol Hepatol, vol.14, pp.641-51, 2017.

N. K. Martin, P. Vickerman, G. Dore, and M. Hickman, The HCV epidemics in key populations (including PWID, prisoners, and MSM): the use of DAAs as treatment for prevention, Curr Opin HIV AIDS, vol.10, pp.374-80, 2015.

J. Grebely, J. Bruneau, J. V. Lazarus, O. Dalgard, P. Bruggmann et al., Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs, Int J Drug Policy, vol.47, pp.51-60, 2017.

S. Nolan, J. Klimas, and E. Wood, Alcohol use in opioid agonist treatment, Addict Sci Clin Pract, vol.11, p.17, 2016.

J. B. Dever, J. H. Ducom, A. Ma, J. Nguyen, L. Liu et al., Engagement in care of high-risk hepatitis C Patients with interferon-free direct-acting antiviral therapies, Dig Dis Sci, vol.62, pp.1472-1481, 2017.

H. Agostini, L. Castera, P. Melin, L. Cattan, and F. Roudot-thoraval, HEPACOM: multicenter, observational prospective study of outcome and monitoring of HCV positive antiviral-naïve patients managed in the French health care system, Gastroenterol Clin Biol, vol.31, pp.1074-80, 2007.

S. H. Mehta, D. L. Thomas, M. S. Sulkowski, M. Safaein, D. Vlahov et al., A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users, AIDS, vol.19, p.179, 2005.

D. L. Thomas, J. Astemborski, R. M. Rai, F. A. Anania, M. Schaeffer et al., The natural history of hepatitis C virus infection: host, viral, and environmental factors, JAMA, vol.284, pp.450-456, 2000.

L. Serfaty, A. Poujol-robert, N. Carbonell, O. Chazouillères, R. E. Poupon et al., Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C, Am J Gastroenterol, vol.97, pp.1807-1819, 2002.

A. K. Singal and B. S. Anand, Mechanisms of synergy between alcohol and hepatitis C virus, J Clin Gastroenterol, vol.41, pp.761-72, 2007.

M. Schwarzinger, S. Baillot, Y. Yazdanpanah, J. Rehm, and V. Mallet, Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, J Hepatol, vol.67, pp.454-61, 2008.

J. Rehm, K. Shield, M. Rehm, G. Gmel, and U. Frick, Alcohol Consumption, Alcohol Dependence and Attributable Burden of Disease in Europe: Potential Gains From Effective Interventions for Alcohol Dependence

, American Psychological Association, p.29, 2012.

H. Font, J. Roelandt, H. Behal, P. Geoffroy, B. Pignon et al., Prevalence and predictors of no lifetime utilization of mental health treatment among people with mental disorders in France: findings from the 'mental health in general population' (MHGP) survey, Soc Psychiatry Psychiatr Epidemiol, vol.53, pp.567-76, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02534681

S. Gitto, L. Micco, F. Conti, P. Andreone, and M. Bernardi, Alcohol and viral hepatitis: a mini-review, Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, vol.41, pp.67-70, 2009.

D. Salmon-ceron, J. Cohen, M. Winnock, P. Roux, F. B. Sadr et al., Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France), BMC Health Serv Res, vol.12, p.59, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00687514

C. E. Costentin, J. Trabut, V. Mallet, S. Darbeda, V. Thépot et al., Management of hepatitis C virus infection in heavy drinkers, Alcohol Alcohol, vol.48, pp.337-379, 2013.

J. I. Tsui, E. C. Williams, P. K. Green, K. Berry, F. Su et al., Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents, Drug Alcohol Depend, vol.169, pp.101-110, 2016.

, Management of HCV with direct acting antivirals, 2016.

, Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection, p.20, 2018.

, European Monitoring Centre for Drugs and Drug Addiction. Health and social responses to drug problems: a European guide, 2017.

J. Bezin, M. Duong, R. Lassalle, C. Droz, A. Pariente et al., The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology, Pharmacoepidemiol Drug Saf, vol.26, pp.954-62, 2017.

P. Tuppin, J. Rudant, P. Constantinou, C. Gastaldi-ménager, A. Rachas et al., Value of a national administrative database to guide public decisions: from the Système national d'information interrégimes de l' Assurance Maladie (SNIIRAM) to the Système national des données de santé (SNDS) in France, Rev Epidemiol Sante Publique, vol.65, pp.149-167, 2017.

M. Chappuis, M. Pauti, A. Tomasino, G. Fahet, F. Cayla et al., Knowledge of HIV and hepatitis B and C status among people living in extreme poverty in France, Med Mal Infect, vol.45, pp.72-79, 2012.

P. Bruggmann, Accessing hepatitis C patients who are difficult to reach: it is time to overcome barriers, J Viral Hepatol, vol.19, pp.829-864, 2012.

C. Treloar, J. Rance, and M. Backmund, Understanding barriers to hepatitis C virus care and stigmatization from a social perspective, Clin Infect Dis, vol.57, pp.51-55, 2013.

P. Bruggmann and A. H. Litwin, Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all, Clin Infect Dis, vol.57, pp.56-61, 2013.

V. Perut, C. Labalette, P. Sogni, I. Ferrand, D. Salmon-céron et al., Access to care of patients with chronic hepatitis C virus infection in a university hospital: is opioid dependence a limiting condition?, Drug Alcohol Depend, vol.104, pp.78-83, 2009.

G. Schomerus, M. Lucht, A. Holzinger, H. Matschinger, M. G. Carta et al., The stigma of alcohol dependence compared with other mental disorders: a review of population studies, Alcohol Alcohol, vol.46, pp.105-117, 2011.

K. Bott, C. Meyer, H. Rumpf, U. Hapke, and U. John, Psychiatric disorders among at-risk consumers of alcohol in the general population, J Stud Alcohol, vol.66, pp.246-53, 2005.

D. Grynberg, P. De-timary, A. V. Heuverswijn, and P. Maurage, Prone to feel guilty: self-evaluative emotions in alcoholdependence, Drug Alcohol Depend, vol.179, pp.78-82, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02536776

B. F. Grant, D. S. Hasin, and D. A. Dawson, The relationship between DSM-IV alcohol use disorders and DSM-IV major depression: examination of the primary-secondary distinction in a general population sample, J Affect Disord, vol.38, pp.113-141, 1996.

J. Uekermann and I. Daum, Social cognition in alcoholism: a link to prefrontal cortex dysfunction?, Addiction, vol.103, pp.726-761, 2008.

P. Roux, D. Rojas-castro, K. Ndiaye, M. Debrus, C. Protopopescu et al., Increased uptake of HCV testing through a community-based educational intervention in difficult-toreach people who inject drugs: results from the ANRS-AERLI study, PLOS ONE, vol.11, p.157062, 2016.

E. J. Aspinall, J. S. Doyle, S. Corson, M. E. Hellard, D. Hunt et al., Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis, Eur J Epidemiol, vol.30, pp.115-144, 2015.

N. H. Latham, A. Pedrana, J. S. Doyle, J. Howell, B. Williams et al., Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugs, J Viral Hepatol, vol.26, pp.919-941, 2019.

N. A. Blackburn, R. C. Patel, and J. E. Zibbell, Improving screening methods for hepatitis C among people who inject drugs: findings from the HepTLC initiative, Public Health Rep, vol.131, pp.91-98, 2012.

A. J. Wade, D. M. Macdonald, J. S. Doyle, A. Gordon, S. K. Roberts et al., The cascade of care for an Australian community-based hepatitis C treatment service, PLOS ONE, 2019.

S. Bajis, G. J. Dore, B. Hajarizadeh, E. B. Cunningham, L. Maher et al., Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: a systematic review, Int J Drug Policy, vol.47, pp.34-46, 2017.

G. Shiha, A. M. Metwally, R. Soliman, M. Elbasiony, N. N. Mikhail et al., An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project, Lancet Gastroenterol Hepatol, vol.3, pp.778-89, 2018.

J. Rehm, A. V. Samokhvalov, and K. D. Shield, Global burden of alcoholic liver diseases, J Hepatol, vol.59, pp.160-168, 2013.

J. Madureira-lima and S. Galea, Alcohol control policies and alcohol consumption: an international comparison of 167 countries, J Epidemiol Community Health, vol.72, pp.54-60, 2018.

R. W. Elder, B. Lawrence, A. Ferguson, T. S. Naimi, R. D. Brewer et al., The effectiveness of tax policy interventions for reducing excessive alcohol consumption and related harms, Am J Prev Med, vol.38, pp.217-246, 2010.

S. Boniface, J. W. Scannell, and S. Marlow, Evidence for the effectiveness of minimum pricing of alcohol: a systematic review and assessment using the Bradford Hill criteria for causality, BMJ Open, 2019.

D. Banerjee and K. R. Reddy, Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy, Aliment Pharmacol Ther, vol.43, pp.674-96, 2016.

M. Sulkowski, H. Vargas, D. Bisceglie, A. Kuo, P. Reddy et al., Effectiveness of Simeprevir plus Sofosbuvir, with or without ribavirin, in real-world patients with HCV genotype 1 infection, Gastroenterology, vol.150, pp.419-448, 2016.

J. A. Gutierrez, E. J. Lawitz, and F. Poordad, Interferon-free, directacting antiviral therapy for chronic hepatitis C, J Viral Hepatol, vol.22, pp.861-70, 2015.

C. Brouard, M. Boussac-zarebska, C. Silvain, J. Durand, V. De-lédinghen et al., Rapid and large-scale implementation of HCV treatment advances in France, BMC Infect Dis, vol.17, p.784, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-02048136

, French Ministry of Social Affairs and Health. Decree [Arrêté du 10 juin 2016 relatif aux conditions de prise en charge de spécialités pharmaceutiques disposant d'une autorisation de mise sur le marché inscrites sur la liste visée à l'article L. 5126-4 du code de la santé publique

S. Ohkoshi, H. Hirono, and S. Yamagiwa, Direct antiviral agent treatment of decompensated hepatitis C virus-induced liver cirrhosis, World J Gastrointest Pharmacol Ther, vol.6, pp.114-123, 2015.

, National observatory of the urban policy, p.25, 2015.

S. Dahrouge, W. Hogg, E. Muggah, and T. Schrecker, Equity of primary care service delivery for low income 'sicker' adults across 10 OECD countries, Int J Equity Health [internet, vol.17, p.182, 2018.

A. C. Seña, S. J. Willis, A. Hilton, A. Anderson, D. A. Wohl et al., Efforts at the frontlines: implementing a hepatitis C testing and linkage-to-care program at the local public health level, Public Health Rep, vol.131, pp.57-64, 2016.

F. Beck, R. Guignard, I. Obradovic, A. Gautier, and L. Karila, Increasing trends in screening for addictives behaviors among general practitioners in France, Rev Epidemiol Sante Publique, vol.59, pp.285-94, 2011.

M. Soyka, Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment, Eur Addict Res, vol.21, pp.78-87, 2015.

. Senbanjo and M. Wolff, Excessive alcohol consumption is associated with reduced quality of life among methadone patients, Addiction, vol.102, pp.257-63, 2006.

A. Nyamathi, C. R. Albarrán, C. Branson, M. Marfisee, F. Khalilifard et al., Correlates of depressive symptoms among alcohol-using methadone maintained adults, Am J Addict, vol.21, pp.49-55, 2012.